[Federal Register Volume 75, Number 165 (Thursday, August 26, 2010)]
[Notices]
[Page 52533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21267]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Department of Health and Human Services, Office of Public
Health and Science, The Presidential Commission for the Study of
Bioethical Issues.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
will conduct a meeting in September. At this meeting, the Commission
will continue discussing the emerging science of synthetic biology,
including its potential benefits and risks, and appropriate ethical
boundaries and principles.
DATES: The meeting will take place Monday, September 13, 2010, from
8:50 a.m. to approximately 4:15 p.m., and Tuesday, September 14, 2010,
from 9 a.m. to approximately noon.
ADDRESSES: Monday, September 13, The Inn at Penn, 3600 Sansom Street,
Philadelphia, PA 19104. Phone 215-222-0200. Tuesday, September 14, The
Annenberg Public Policy Center, 202 South 36th Street, Philadelphia, PA
19104. Phone 215-898-9400.
FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of
Communications, The Presidential Commission for the Study of Bioethical
Issues, 1425 New York Avenue, NW., Suite C-100, Washington, DC 20005.
Telephone: 202/233-3960. E-mail: info@bioethics.gov. Additional
information may be obtained by viewing the Web site: http://www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act, Public Law 92-463, 5 U.S.C. App., notice is hereby given that the
Presidential Commission for the Study of Bioethical Issues (PCSBI) will
be conducting a meeting. The meeting will be held from 8:50 a.m. to
approximately 4:15 p.m. on Monday, September 13, 2010, at the Inn at
Penn, 3600 Sansom Street, Philadelphia, PA 19104, and from 9 a.m. to
approximately noon on Tuesday, September 14, 2010, at The Annenberg
Public Policy Center, 202 South 36th Street, Philadelphia, PA 19104.
The meeting will be open to the public with attendance limited to space
available. The meeting will also be Web cast.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the PCSBI to serve as a public forum and
advise him on bioethical issues generated by novel and emerging
research in biomedicine and related areas of science and technology.
The Commission is charged to identify and promote policies and
practices that assure ethically responsible conduct of scientific
research, healthcare delivery, and technological innovation. In
undertaking these duties, the Commission will examine specific
bioethical, legal, and social issues related to potential scientific
and technological advances; examine diverse perspectives and
possibilities for useful international collaboration on these issues,
and recommend legal, regulatory, or policy actions as appropriate. The
main agenda items for this meeting involve further discussion of the
opportunities and benefits to the public of the emerging science of
synthetic biology, the challenges and risks, and the ethical boundaries
that may be important to formulation of public policy with regard to
this advancing science. The Commission also will hear more from the
perspective of faith communities and others. The draft meeting agenda
and other information about PCSBI, including information about access
to the Web cast, will be available at http://www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Individuals who would like to provide
public comment at the meeting should notify Ms. Diane Gianelli,
Director of Communications, by telephone at 202-233-3960, or e-mail at
diane.gianelli@bioethics.gov. Anyone planning to attend the meeting who
needs special assistance, such as sign language interpretation or other
reasonable accommodations, should also notify Ms. Gianelli in advance
of the meeting. The Commission will make every effort to accommodate
persons who need special assistance.
Written comments will also be accepted in accord with the
Commission's existing request for public comment on the issues before
the Commission. Please address written comments by e-mail to
info@bioethics.gov, or by mail to the following address: Public
Commentary, The Presidential Commission for the Study of Bioethical
Issues, 1425 New York Ave., NW., Suite C-100, Washington, DC 20005.
Comments will be publicly available, including any personally
identifiable or confidential business information that they contain.
Trade secrets should not be submitted.
Dated: August 17, 2010.
Valerie H. Bonham,
Executive Director, The Presidential Commission for the Study of
Bioethical Issues.
[FR Doc. 2010-21267 Filed 8-25-10; 8:45 am]
BILLING CODE 4154-06-P